Pharmacogenetics and Genomics

Associations between TMEM196 polymorphisms and NSAID-exacerbated respiratory disease in asthma
pp. 69-75(7)
Authors: Lee, Jong-Uk; Chang, Hun Soo; Baek, Dong Gyu; Shin, Hyoung Doo; Park, Choon-Sik; Park, Jong-Sook

International survey of patients undergoing percutaneous coronary intervention and their attitudes toward pharmacogenetic testing
pp. 76-83(8)
Authors: Pereira, Naveen L.; So, Derek; Bae, Jang-Ho; Chavez, Ivan; Jeong, Myung Ho; Kim, Sang Wook; Madan, Mina; Graham, John; O’Cochlain, Fearghas; Pauley, Nicole; Lennon, Ryan J.; Bailey, Kent; Hasan, Ahmed; Baudhuin, Linnea M.; Bell, Malcolm R.; Lerman, Amir; Goodman, Shaun; Mathew, Verghese; Farkouh, Michael; Rihal, Charanjit S.

Association of FAM65B, AGBL4, and CUX2 genetic polymorphisms with susceptibility to antituberculosis drug-induced hepatotoxicity: validation study in a Chinese Han population
pp. 84-90(7)
Authors: Pan, Hongqiu; Yang, Miaomiao; Lu, Lihuan; Tao, Bilin; He, Xiaomin; Chen, Hongbo; Yi, Honggang; Tang, Shaowen

PharmGKB summary: Ondansetron and tropisetron pathways, pharmacokinetics and pharmacodynamics
pp. 91-97(7)
Authors: Huddart, Rachel; Altman, Russ B.; Klein, Teri E.